Establishment Labs Holdings Inc. (ESTA)

Name: Establishment Labs Holdings Inc. (ESTA) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name ESTABLISHMENT LABS HOLDINGS INC. · CIK 0001688757 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Establishment Labs Holdings Inc. reported revenue of $211.08M. Revenue grew 27.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $245.82M.

Key ratios (year ended 2025-12-31)

69.3%

Gross margin

-18.5%

Operating margin

-24.2%

Net margin

-216.9%

Return on year-end equity

27.1%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Revenue	$245.82M	$211.08M	$166.03M	$165.15M	$161.70M	$126.68M	$84.68M	$89.56M	$61.21M	$34.68M
Cost of Revenue	$72.54M	$64.77M	$56.50M	$58.17M	$55.10M	$41.28M	$32.17M	$34.70M	$25.09M	$16.98M
Gross Profit	$173.27M	$146.31M	$109.53M	$106.98M	$106.59M	$85.40M	$52.50M	$54.86M	$36.12M	$17.70M
R&D Expense	$20.33M	$20.25M	$19.71M	$26.43M	$20.27M	$18.32M	$13.79M	$14.99M	$12.69M	$6.86M
Operating Income	-$18.76M	-$39.01M	-$49.99M	-$65.03M	-$39.66M	-$25.14M	-$27.92M	-$30.94M	-$23.86M	-$19.98M
Depreciation & Amortization	n/a	$6.20M	$4.70M	$2.80M	$2.50M	$2.50M	n/a	n/a	n/a	n/a
EBITDA	n/a	-$32.81M	-$45.29M	-$62.23M	-$37.16M	-$22.64M	n/a	n/a	n/a	n/a
Net Income	-$38.89M	-$51.06M	-$84.60M	-$78.50M	-$75.21M	-$41.14M	-$38.12M	-$38.15M	-$21.10M	-$34.90M
EPS (Diluted)	n/a	-$1.72	-$3.00	-$3.07	-$3.08	-$1.72	-$1.63	-$1.86	n/a	n/a
Total Assets	$351.93M	$357.17M	$346.83M	$268.64M	$211.06M	$139.53M	$156.39M	$116.53M	$116.57M	$57.09M
Total Liabilities	$330.32M	$333.62M	$293.74M	$250.25M	$219.25M	$88.79M	$81.43M	$76.92M	$47.09M	$62.11M
Long-Term Debt	n/a	n/a	$0	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders' Equity	$21.61M	$23.55M	$53.09M	$18.39M	-$8.19M	$50.74M	$74.96M	$39.61M	$69.48M	-$5.01M
Cash & Equivalents	$71.16M	$75.57M	$90.35M	$40.03M	$66.36M	n/a	n/a	n/a	$52.64M	$10.86M
Operating Cash Flow	-$32.32M	-$50.89M	-$58.52M	-$88.51M	-$52.17M	-$27.53M	-$12.51M	-$29.98M	-$33.88M	-$31.97M
Capital Expenditures	$9.18M	$6.05M	$6.11M	$7.91M	$2.85M	$2.42M	$2.11M	$6.29M	$1.73M	$901.0K
Free Cash Flow	-$41.51M	-$56.94M	-$64.63M	-$96.42M	-$55.02M	-$29.96M	-$14.62M	-$36.27M	-$35.62M	-$32.87M
Share Repurchases	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$0	$4.51M
Shares Outstanding	29.79M	29.30M	28.79M	26.09M	24.41M	24.08M	23.52M	20.65M	20.26M	n/a
Weighted Average Diluted Shares	n/a	29.62M	28.16M	25.60M	24.46M	23.97M	23.32M	20.54M	n/a	n/a
EPS (Basic)	n/a	-$1.72	-$3.00	-$3.07	-$3.08	-$1.72	-$1.63	-$1.86	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView